Abbott will acquire the Solvay Group, including the pharmaceutical and vaccine business, for $6.6 billion in cash, the company announced.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.